| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.037 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |